Regeneron Pharmaceuticals and Sanofi will lower the price of their cholesterol drug Praluent by up to $9,500 annually for Express Scripts customers. In return, Express Scripts will grant the ...
Express Scripts has announced a new pharmacy network option that offers "cost plus" drug pricing for employers and health plans. Clients pay the estimated acquisition cost that the pharmacy pays for ...
Politicians have been hitting hard at pharma for months and years, using terms such as “skyrocketing,” “astronomical” or “soaring” to describe drug costs. But leading pharmacy benefits manager Express ...
Express Scripts and Prime Therapeutics said Dec. 19 they are entering into a three-year collaboration to lower drug costs for their more than 100 million clients. The collaboration between the two ...
As pharmacy benefit managers (PBMs) face more scrutiny about their practices and rising drug costs, Express Scripts unveiled new solutions last week that aim to improve price transparency and drive ...
At-home drug tests are urine or saliva tests that can identify if illegal or prescriptions drugs are present in your body. These tests are an alternative to going in person to a laboratory or other ...
Express Scripts ClearNetwork SM offers employers and health plans a new option for simple, "cost-plus" pharmacy pricing for brand, generic, and specialty medications. "We are constantly innovating to ...
ATLANTA, Aug. 21, 2013 /PRNewswire/ -- Atlantic Pharmaceuticals, Inc., today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8,507,001 that contains ...
Drug tests identify tetrahydrocannabinol (THC) or its metabolites. Although these tests do not screen for CBD, some CBD products contain low quantities of THC that could theoretically make a person ...
Frank T. Messina, General Counsel of Script Care Ltd. in Beaumont, Texas. Somewhere, working quietly in the shadow of headlines about high prescription drug prices, is general counsel Frank Messina of ...
Cigna Group’s Express Scripts announced plans to offer a “cost-plus” drug pricing model for its clients next year amid growing scrutiny of pharmacy benefit managers. Employers, health plans and ...